Data / Drug companies / Antiemetic
Antiemetic drugs: 13 drugs from 85 companies in the FDA NDC directory
Antiemetic is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 170 products in this class from 85 companies, covering 13 drugs by generic name. The main marketing category is over the counter monograph drugs, and the newest product started marketing on October 6, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 85Companies
- 170Products
- 13Drugs by generic name
Drugs in the Antiemetic class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Meclizine hydrochloride | 84 | 41 |
| Meclizine hcl | 38 | 32 |
| Meclizine | 16 | 10 |
| Trimethobenzamide hydrochloride | 7 | 7 |
| Meclizine hcl 12.5 mg | 6 | 6 |
| Meclizine hydrochloride chewable | 4 | 4 |
| Meclizine hcl 25mg | 3 | 3 |
| Meclizine hcl 25mg chewable tablets | 3 | 3 |
| Meclizine hydrocloride | 3 | 3 |
| Meclazine hydrochloride tablet | 2 | 2 |
| Meclizine hcl 12.5mg | 1 | 1 |
| Meclizine hcl 25 mg | 1 | 1 |
| Tigan(r) (trimethobenzamide hydrochloride) | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 11 | tablet; tablet, chewable | Generic drugs (ANDA) | September 14, 2023 |
| Medtech Products Inc. | 7 | tablet, chewable; tablet | Over the counter monograph drugs | August 1, 2026 |
| A-S Medication Solutions | 6 | tablet; tablet, chewable | Generic drugs (ANDA) | September 14, 2023 |
| NuCare Pharmaceuticals,Inc. | 6 | tablet; tablet, chewable | Generic drugs (ANDA) | October 30, 2020 |
| Proficient Rx LP | 5 | tablet | Over the counter monograph drugs | January 15, 2020 |
| Rising Pharma Holdings, Inc. | 5 | tablet; tablet, chewable | Authorized generics (NDA) | August 18, 2022 |
| Asclemed USA, Inc. | 4 | tablet | Authorized generics (NDA) | January 15, 2020 |
| Chartwell RX, LLC | 4 | tablet, film coated; capsule | Generic drugs (ANDA) | November 21, 2023 |
| Preferred Pharmaceuticals Inc. | 4 | tablet; tablet, chewable | Over the counter monograph drugs | August 3, 2026 |
| Redpharm Drug | 4 | tablet | Generic drugs (ANDA) | September 14, 2023 |
| Walgreen Company | 4 | tablet, chewable; tablet, orally disintegrating | Over the counter monograph drugs | May 31, 2024 |
| WellSpring Pharmaceutical Corporation | 4 | tablet, chewable | Over the counter monograph drugs | April 1, 2025 |
| Amneal Pharmaceuticals LLC | 3 | tablet | Generic drugs (ANDA) | February 12, 2010 |
| Apnar Pharma LP | 3 | tablet | Over the counter monograph drugs | November 21, 2022 |
| Aurobindo Pharma Limited | 3 | tablet | Generic drugs (ANDA) | September 14, 2023 |
| Advance Pharmaceutical Inc. | 2 | tablet; tablet, chewable | Over the counter monograph drugs | July 1, 2013 |
| Advanced Rx LLC | 2 | tablet; tablet, chewable | Over the counter monograph drugs | September 1, 2025 |
| American Health Packaging | 2 | tablet | Generic drugs (ANDA) | September 8, 2023 |
| Amerisource Bergen | 2 | tablet; tablet, chewable | Over the counter monograph drugs | March 19, 2024 |
| Amneal Pharmaceuticals of New York LLC | 2 | tablet | Generic drugs (ANDA) | April 22, 2022 |
| Aphena Pharma Solutions - Tennessee, LLC | 2 | tablet, chewable | Over the counter monograph drugs | October 30, 2020 |
| AvPAK | 2 | tablet | Generic drugs (ANDA) | August 8, 2013 |
| BluePoint Laboratories | 2 | tablet, chewable; tablet | Over the counter monograph drugs | March 14, 2022 |
| CVS Pharmacy | 2 | tablet; tablet, chewable | Over the counter monograph drugs | August 13, 2020 |
| CVS Woonsocket Prescription Center, Incorporated | 2 | tablet, chewable | Over the counter monograph drugs | September 26, 2025 |
| Direct_Rx | 2 | tablet | Authorized generics (NDA) | September 1, 2022 |
| Epic Pharma, LLC | 2 | tablet | Generic drugs (ANDA) | April 30, 2012 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 2 | capsule; tablet | Generic drugs (ANDA) | June 25, 2026 |
| Major Pharmaceuticals | 2 | tablet | Generic drugs (ANDA) | April 22, 2022 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 2 | tablet | Generic drugs (ANDA) | September 14, 2023 |
| Pharbest Pharmaceuticals, Inc. | 2 | tablet, chewable; tablet | Over the counter monograph drugs | February 1, 2018 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | April 30, 2012 |
| QPharma, Inc. | 2 | tablet | Generic drugs (ANDA) | April 22, 2022 |
| Reliable 1 Laboratories LLC | 2 | tablet | Over the counter monograph drugs | November 1, 2015 |
| Remedyrepack Inc. | 2 | tablet | Authorized generics (NDA) | August 2, 2023 |
| Rite Aid Corporation | 2 | tablet, chewable; tablet | Over the counter monograph drugs | November 10, 2023 |
| Rugby Laboratories | 2 | tablet; tablet, chewable | Over the counter monograph drugs | October 30, 2020 |
| St. Mary's Medical Park Pharmacy | 2 | tablet | Authorized generics (NDA) | October 6, 2026 |
| Strategic Sourcing Services LLC | 2 | tablet; tablet, chewable | Over the counter monograph drugs | May 30, 2025 |
| The Procter & Gamble Manufacturing Company | 2 | tablet | Over the counter monograph drugs | September 1, 2026 |
| Zydus Lifesciences Limited | 2 | tablet | Generic drugs (ANDA) | October 29, 2020 |
| Zydus Pharmaceuticals USA Inc. | 2 | tablet | Generic drugs (ANDA) | October 29, 2020 |
| Acme United Corporation | 1 | tablet | Over the counter monograph drugs | June 18, 2021 |
| Advanced Rx of Tennessee, LLC | 1 | tablet | Authorized generics (NDA) | February 2, 2025 |
| Army and Air Force Exchange Service | 1 | tablet | Over the counter monograph drugs | June 24, 2002 |
| Bi-Mart | 1 | tablet, chewable | Over the counter monograph drugs | January 14, 2026 |
| Bpi Labs LLC | 1 | injection | Generic drugs (ANDA) | July 1, 2026 |
| CVS Pharmacy | 1 | tablet, orally disintegrating | Over the counter monograph drugs | August 27, 2015 |
| Cardinal Health 110, LLC. DBA Leader | 1 | tablet | Over the counter monograph drugs | May 11, 2021 |
| Chain Drug Marketing Association, Inc. | 1 | tablet, chewable | Over the counter monograph drugs | March 27, 2024 |
| Coupler LLC | 1 | tablet | Authorized generics (NDA) | August 21, 2026 |
| Dolgencorp, Inc. (dollar General & Rexall) | 1 | tablet | Over the counter monograph drugs | June 1, 2019 |
| Family Dollar (family Wellness) | 1 | tablet | Over the counter monograph drugs | December 29, 2023 |
| Geri-Care Pharmaceuticals, Corp | 1 | tablet | Over the counter monograph drugs | May 1, 2022 |
| H E B | 1 | tablet | Over the counter monograph drugs | June 24, 2019 |
| HF Acquisition Co LLC, DBA HealthFirst | 1 | injection | New drug applications (NDA) | January 10, 2020 |
| Henry Schein, Inc. | 1 | injection | New drug applications (NDA) | January 11, 2022 |
| Kroger Company | 1 | tablet | Over the counter monograph drugs | June 3, 2019 |
| Lil' Drug Store Products, Inc. | 1 | tablet | Over the counter monograph drugs | September 30, 2024 |
| Lupin Pharmaceuticals,Inc. | 1 | capsule | Generic drugs (ANDA) | January 17, 2011 |
| Lydia Co., Ltd. | 1 | liquid | Other unapproved drugs | January 23, 2023 |
| Meijer Distribution Inc | 1 | tablet | Over the counter monograph drugs | March 27, 2019 |
| Navajo Manufacturing Company Inc. | 1 | tablet | Over the counter monograph drugs | February 18, 2026 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | October 7, 2022 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | June 11, 2024 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, chewable | Over the counter monograph drugs | February 1, 2018 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, chewable | Over the counter monograph drugs | October 30, 2020 |
| Par Health USA, LLC | 1 | injection | New drug applications (NDA) | August 1, 2008 |
| PuraCap Pharmaceutical LLC | 1 | tablet, chewable | Over the counter monograph drugs | November 28, 2017 |
| Richmond Pharmaceuticals, Inc. | 1 | tablet, chewable | Over the counter monograph drugs | May 1, 2015 |
| Rising Pharma Holdings, Inc. | 1 | tablet | Over the counter monograph drugs | July 22, 2024 |
| Safeway | 1 | tablet | Over the counter monograph drugs | June 24, 2002 |
| Salado Sales, Inc. | 1 | tablet | Over the counter monograph drugs | June 24, 2002 |
| Sato Pharmaceutical Co., Ltd. | 1 | tablet | Over the counter monograph drugs | May 1, 2021 |
| Select Consumer Group | 1 | tablet | Over the counter monograph drugs | September 30, 2024 |
| Shield Pharmaceuticals Corp | 1 | tablet, film coated | Over the counter monograph drugs | December 6, 2023 |
| Sportpharm LLC | 1 | tablet | Over the counter monograph drugs | February 27, 2026 |
| Target Corporation | 1 | tablet | Over the counter monograph drugs | November 5, 2025 |
| Time Cap Laboratories, Inc | 1 | tablet, chewable | Over the counter monograph drugs | August 9, 2010 |
| Topco Associates LLC | 1 | tablet | Over the counter monograph drugs | May 30, 2019 |
| Ulai Health LLC | 1 | tablet | Over the counter monograph drugs | July 8, 2019 |
| Unifirst First Aid Corporation | 1 | tablet | Over the counter monograph drugs | December 14, 2020 |
| United Natural Foods, Inc. DBA Unfi | 1 | tablet | Over the counter monograph drugs | June 24, 2002 |
| Wal-Mart Stores Inc | 1 | tablet | Over the counter monograph drugs | June 24, 2002 |
| Walmart Inc. | 1 | tablet | Over the counter monograph drugs | May 16, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 115 | 67.6% |
| Tablet, chewable | 39 | 22.9% |
| Capsule | 4 | 2.4% |
| Injection | 4 | 2.4% |
| Tablet, film coated | 4 | 2.4% |
| Tablet, orally disintegrating | 2 | 1.2% |
| Liquid | 1 | 0.6% |
| Powder | 1 | 0.6% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.